Patient-Helpdesk.com

genentech patient assistance program

by Perry Bogisich Published 1 year ago Updated 1 year ago
image

Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs. ACTEMRA ® (tocilizumab) CO-PAY PROGRAM‎

Full Answer

See more

image

What is the Genentech Patient Foundation?

The Genentech Patient Foundation gives free medicine to people who have financial concerns, because we believe that every person who is prescribed a Genentech medicine should get the treatment they need. Help for People With or Without Health Insurance.

What Is Genentech access Solutions?

Genentech Access Solutions Explains insurance coverage to people taking Genentech medicines and connects them to support programs.

What drugs does Genentech make?

Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...

What is Ophthalmology access solutions?

We focus on access so you can focus on health Genentech Ophthalmology Access Solutions is a program that helps people who are taking a Genentech medicine. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment.

Who makes Valganciclovir?

Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.

Does Pfizer own Genentech?

Roche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year. But it is different from the other two — Pfizer's $68 billion proposal to acquire Wyeth and Merck's $41 billion deal with Schering-Plough — in crucial ways.

What is Genentech best known for?

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

Why did Roche buy Genentech?

For another, Roche went into the deal with the goal of preserving the innovative, entrepreneurial culture that had transformed Genentech from a start-up to a standout, one that had developed Roche's three best-selling products — the cancer drugs Avastin, Herceptin and Rituxan.

How many drugs does Genentech have?

Genentech, Inc. manufactures, markets and/or distributes more than 47 drugs in the United States.

Which one of these is an approved drug by the firm Genentech?

The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab) Activase® (alteplase) Alecensa® (alectinib)

What drugs does Roche make?

All. Actemra/RoActemra. Alecensa. ... Anaemia. Mircera. NeoRecormon.Cancer (blood tumours) Gazyva/Gazyvaro. MabThera / Rituxan. ... Cancer (blood cancers) Alecensa. Avastin. ... Dermatology. Roaccutane/Accutane.Haemophilia. Hemlibra.Infectious Diseases. Actemra/RoActemra. Copegus. ... Inflammatory & Autoimmune Diseases. Actemra/RoActemra. CellCept.More items...

What MS drugs does Genentech make?

About OCREVUS OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).

Apply For Help

If you are a health care provider, click below to learn how to apply online or via fax.

Health Care Providers

Health Care Providers can submit the completed Patient Consent and Prescriber Foundation form in two ways:

Patients

Step 1: Complete the online Patient Consent Form, which is available in English and Spanish: Patient Consent Form | Formulario de Consentimiento del Paciente

Why is Genentech patient foundation important?

People can have trouble getting their medicines for many reasons. The Genentech Patient Foundation helps people in need, whether they have insurance or not.

How much does Genentech add to a household?

For households larger than 4 people, add $25,000 for each extra person. There is no maximum number of people you may add. The Genentech Patient Foundation assists patients living in the United States, who are being treated by a physician licensed in the United States.

Have you been prescribed a participating Genentech medicine?

If one of these situations applies to you, you may qualify for support from the Genentech Patient Foundation. Please complete the enrollment forms to apply for help.

Supporting People Who Need Help Paying For Our Medicines

Genentech has always focused on developing breakthrough medicines for serious illnesses. We believe every person should get the Genentech medicine they need, and we offer programs to help make this happen.

Learn How We Help

Explains insurance coverage to people taking Genentech medicines and connects them to support programs.

Who provides Genentech medicine?

The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*

What is Erivedge Access Solutions?

For eligible patients with commercial or public health insurance, Erivedge Access Solutions offers referrals to independent co-pay assistance foundations.†

Does Erivedge refer to Genentech?

If eligible commercially insured patients need assistance with their out-of-pocket costs, Erivedge Access Solutions can refer them to the Genentech Oncology Co-pay Assistance Program.*

How to report side effects of Genentech?

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information , including Boxed WARNINGS and Medication Guide, for additional Important Safety Information.

How long after stopping CellCept can you donate blood?

You should not donate blood while taking CellCept and for at least 6 weeks after stopping CellCept.

What is cellept used for?

CellCept. ®. (mycophenolate mofetil) is a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. Rejection is when the body’s immune system perceives the new organ as a “foreign” threat and attacks it. CellCept is used with other medicines containing cyclosporine ...

How to contact mycophenolateREMS?

by phone at 1-800-617-8191 or. by visiting the Risk Evaluation and Mitigation Strategy (REMS) website at www.mycophenolateREMS.com. The purpose of this registry is to gather information about the health of you and your baby. Increased risk of getting certain cancers.

What are the infections that can happen with CellCept?

Viral infections that can happen with CellCept include: shingles, other herpes infections , and cytomegalovirus (CMV).

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9